#IPVSPaperOfTheWeek
This experimental study on HPV E7 showed that E7 hijacks CRL2–ZER1 to promote Rb degradation. A first-in-class small molecule disrupts E7–ZER1 association and selectively inhibits HPV-positive tumor growth in experimental models.

🔗https://pubmed.ncbi.nlm.nih.gov/42519832/

#IPVSPaperOfTheWeek
November 13, 2026 at 8:58 AM
New mechanistic evidence shows how the HPV16 E2 protein rewires the host DNA damage response during epithelial differentiation, displacing CIP2A from TOPBP1 to activate ATM signaling and support viral genome stability.

🔗Full paper: bit.ly/4812o20

#IPVSPaperOfTheWeek
November 6, 2026 at 8:14 AM
New long-term evidence shows sustained HPV vaccine immunogenicity and low HPV-related disease among women living with HIV for up to 9 years.

Full paper link: bit.ly/4BRSoWH

#IPVSPaperOfTheWeek
October 30, 2026 at 8:57 AM
This experimental study demonstrated that GATA3 downregulates E6/E7 mRNA levels in HPV16/18. Reduced expression correlates with cervical lesion grade and viral oncogene transcripts, while absence correlates with higher cancer stages.

🔗https://bit.ly/4hM5Q6t

#IPVSPaperOfTheWeek
October 9, 2026 at 6:25 AM
A new study explores how host immune pressure may shape HPV16 evolution, with implications for viral persistence and disease outcomes.

Full paper link: www.nature.com/articles/s41...

#IPVSPaperOfTheWeek

@chasewnelson.bsky.social
@lisamirabello.bsky.social
@nature.com
@einsteinmededu.bsky.social
September 25, 2026 at 10:15 AM
New prospective evidence suggests that on-treatment HPV ctDNA could help identify patients with HPV-positive oropharyngeal cancer who may be suitable for de-intensified therapy.

🔗https://www.nature.com/articles/s41467-026-72984-7

#IPVSPaperOfTheWeek
September 18, 2026 at 1:53 PM
The effect of #HPVvaccination on precancerous lesions and invasive cervical cancer in a low-vaccination-coverage setting in Germany: a retrospective cohort analysis.

🔗https://www.sciencedirect.com/science/article/pii/S2666776226002425

#IPVSPaperOfTheWeek
September 11, 2026 at 8:26 AM
HPV vaccination benefits extend beyond cervical cancer: across 117 low- and middle-income countries, vaccination could avert nearly 5 million non-cervical cancer cases and 3 million deaths by 2100.

🔗https://pubmed.ncbi.nlm.nih.gov/42674727/

#IPVSPaperOfTheWeek
September 4, 2026 at 6:48 AM
New study: DNA methylation testing on cervical biopsies found positivity only in high-grade (HSIL) lesions, tied to HPV16 and higher Ki-67 - all low-grade samples were negative. Could help stratify lesion risk.

🔗https://bit.ly/46u6T4e

#IPVSPaperOfTheWeek
August 28, 2026 at 1:54 PM
New phase 3 evidence from China shows that an E. coli-produced nine-valent HPV vaccine demonstrated high efficacy against persistent infection with five additional high-risk HPV types.

🔗 bit.ly/4qlveTc

#IPVSPaperoftheWeek
August 14, 2026 at 8:39 AM
Notably, some #HPV16 #E6/E7 variants found in #CIN3 or cancer are loss-of-function, with impaired targeting of p53, pRB or PTPN14.

🔗https://journals.asm.org/doi/10.1128/jvi.00236-26

#IPVSPaperOfTheWeek
August 7, 2026 at 7:50 AM
This narrative review synthesizes evidence that HPV DNA, E6/E7 mRNA, and DNA methylation biomarkers reflect complementary stages of persistent HPV infection and may improve HPV-based screening and risk stratification.

🔗https://pubmed.ncbi.nlm.nih.gov/41899583/

#IPVSPaperoftheWeek
July 31, 2026 at 8:23 AM
A comprehensive review highlights the rapid progress of therapeutic HPV vaccines designed to treat existing HPV-related lesions and cancers by targeting viral oncoproteins.

🔗Link to the full paper: bit.ly/4wsriSw

#IPVSPaperOfTheWeek
July 24, 2026 at 7:47 AM
A new study provides new insights into HPV diversity across cutaneous squamous cell carcinomas, eyebrow hair, and warts in Asian patients, revealing patterns shaped by organ transplantation and immunosuppression.
 
Full paper 🔗 bit.ly/3STp7c6
 
#IPVSPaperoftheWeek
July 17, 2026 at 7:23 AM
New evidence from India: first-void urine HPV testing performs comparably to vaginal self-sampling & is highly acceptable to women — a feasible option for expanding cervical cancer screening in resource-limited settings.
 
📄 Read more: bit.ly/IPVSPaperoft...
 
#IPVSPaperoftheWeek
July 10, 2026 at 6:34 AM
This population-based study from England found a marked fall in cervical cancer mortality following HPV vaccination.

Highlights are summarised below ⬇️
Read the full paper here: https://bit.ly/IPVSpaperoftheweek

#IPVSPaperoftheWeek
July 3, 2026 at 5:55 AM
This multinational study found a positive association between higher monthly alcohol consumption and oral high-risk HPV (HR-HPV) infection among men, suggesting alcohol as a modifiable risk factor: pubmed.ncbi.nlm.nih.gov/42005087

Highlights are summarised below ⬇️

#IPVSPaperoftheWeek
June 26, 2026 at 6:33 AM
A new study from Pakistan adapted the WHO Behavioral and Social Drivers (BeSD) framework for HPV vaccination and found that culture itself functions as a distinct driver of vaccine uptake.

Highlights are summarised below ⬇️ and full paper link: bit.ly/4oCC6KV

#IPVSPaperoftheWeek
June 19, 2026 at 11:21 AM
In CD28-deficient mice, CD28 is shown to be dispensable for #papillomavirus_clearance—but critical for efficient control at cutaneous and mucosal sites. MmuPV1 persists longer, with impaired T-cell recruitment and weaker antiviral CTL function.

👉 Full paper: bit.ly/4dzRySP

#IPVSPaperoftheWeek
May 22, 2026 at 6:40 AM
This state-of-the-art review summarizes next-generation HPV vaccines and shows strong efficacy and emerging high-valency and L2-based platforms, though real-world evidence is needed for cost-effectiveness.

Highlights are summarised below ⬇️ and full paper link: bit.ly/495Fqrw

#IPVSPaperoftheWeek
May 15, 2026 at 7:44 AM
Real world evidence from school-based #HPVvaccine program in #SouthAfrica showing reduction in HPV prevalence among adolescent girls utilizing a #2dose program.

Highlights are summarised below ⬇️ and full paper link: bit.ly/48FuSzd

#CervicalCancer #IPVSPaperoftheWeek
April 24, 2026 at 1:00 PM
New population-based study from Portugal shows that #HPVVaccination and long-standing screening are associated with substantial reductions in high-grade cervical lesions, particularly among younger women, alongside a shift in HPV genotype distribution.

🔗 bit.ly/3NZMf6x

#IPVSPaperoftheWeek
March 27, 2026 at 8:11 AM
Follow-up from the #PITVIN Study showed the risk of long-term recurrence of #vulvar HSIL does not differ significantly between primary treatment with imiquimod or surgical treatment.

Highlights are summarised below ⬇️ and full paper link: bit.ly/4dyBu5r

#IPVSPaperoftheWeek
March 20, 2026 at 6:43 AM
Longitudinal ctDNA analysis during chemoradiation and follow-up identifies patients at high risk of recurrence and may enable more personalized surveillance strategies in anal cancer 🔗 bit.ly/4b8JOYe

Highlights are summarised below ⬇️

#IPVSPaperoftheWeek
March 13, 2026 at 7:13 AM
New modelling evidence across 67 low and lower-middle income countries shows that single-dose HPV vaccination with extended catch-up could be among the most efficient strategies for cervical cancer prevention

Highlights are summarized below ⬇️

🔗 bit.ly/4ujNyh5

#IPVSPaperoftheWeek #HPV
March 6, 2026 at 6:09 AM